









Markets
/
Stocks
/
nasdaq-mgtx
/

MeiraGTx Holdings PLC

MGTX

View Detailed Chart

7.650USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

607.55MMarket Cap

LossP/E TTM



MeiraGTx Holdings PLC

7.650

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

0.00%

5 Days

-8.60%

1 Month

+1.86%

6 Months

+24.80%

Year to Date

+25.62%

1 Year

+60.04%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 6 analysts

BUY

Current Rating

27.500

Target Price

259.48%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

MeiraGTx Holdings PLC

MGTX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(2)

Buy(3)

Indicators

Sell(2)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.375

Neutral

RSI(14)

46.016

Neutral

STOCH(KDJ)(9,3,3)

11.579

Oversold

ATR(14)

0.388

Low Volatility

CCI(14)

-178.931

Sell

Williams %R

86.364

Oversold

TRIX(12,20)

0.661

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

7.898

Sell

MA10

8.194

Sell

MA20

8.329

Sell

MA50

6.986

Buy

MA100

6.647

Buy

MA200

6.471

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.

Ticker SymbolMGTX

CompanyMeiraGTx Holdings PLC

CEODr. Alexandria Forbes, Ph.D.

Websitehttps://meiragtx.com/